Home / Inspections / 1223875

FDA Inspection 1223875 — Foulk & Whitten Nevada Center For Reproductive Medicine

Foulk & Whitten Nevada Center For Reproductive Medicine — FEI 3004105841

The FDA completed an inspection of Foulk & Whitten Nevada Center For Reproductive Medicine on November 15, 2023 in Reno, NV. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 15, 2023
Fiscal Year
2024
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Reno, NV (United States)

Facility

Other inspections at this facility

  • 1084676 (VAI Thu Mar 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 993202 (VAI Wed Nov 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 883672 (NAI Thu Jun 05 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 727117 (NAI Tue May 31 2011 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 583033 (NAI Wed May 06 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources